News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Behind Drug Development: How AGC Biologics Brings Hope to Life
For Jean-Baptiste “JB” Agnus, the company’s purpose of bringing hope to patients fuels his work AGC Biologics. “Each individual, each team member at AGC Biologics,
Kathy Surace-Smith named a PSBJ Director of the Year
An employee at Nanostring Technologies, a Seattle-based biotech startup, was named a Business Journal director of the year for 2023. Kathy Surace-Smith is senior vice
Viome Life Sciences banks $86.5M round, partners with CVS to sell at-home diagnostic tests
Viome Life Sciences, a biotech startup in the Seattle area, acquired $86.5 million in Series C funding and confirmed that its gut microbiome test will
These are the 6 best big cities in the U.S. to launch a startup
Seattle ranks fifth in the best American cities to launch a startup company, according to a recent survey from Statista. The west coast city received
Americans rate Seattle one of safest cities in Gallup poll
Seattle is viewed by Americans as one of the safest cities in the country, according to a recent poll from Gallup. The survey involved roughly
Curi Bio lands over $4.4M in NIH grants for two projects
Curio Bio, a Seattle-based biotech company, received $4.4 million from the National Institutes of Health. The funding will be used to support two projects, one
Seattle biotech startup Talus Bio awarded $4.3 to fight cancer
Talus Bioscience, a Seattle-based biotech, received $4.3 million from the Washington Andy Hill Cancer Research Endowment Fund and the National Institutes of Health. The grant
Kundig-designed life science proposal lands at Interbay
A new life science building is set to be built in Seattle’s Interbay neighborhood, overlooking Terminal 86 and shouldering Expedia’s headquarters. The building is nearly
Seagen’s breast cancer therapy succeeds in late-stage study
Bothell-based biotech company Seagen found success with one of its breast cancer therapies on Wednesday. A combination of the treatment, named Tuksya, met the goal
AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement
AGC Biologics, a biotech company headquartered in Bothell, is partnering with pharmaceutical company Asahi Kasei to develop a drug substance that will support antibody therapies.
Absci and Caltech Collaborate to Accelerate Affordable HIV Therapeutic Vaccine
Absci, a biotech firm based in Vancouver, Washington, received a grant from the Bill & Melinda Gates Foundation to fund its partnership with the California
Seattle company founded by Nobel Prize winner plans human tests for experimental COVID-19 drug
Seattle biotech company Cocrystal Pharma received permission from regulators to begin early-stage clinical trials for its COVID-19 and norovirus treatments. Previously, the company focused on